Notably, previous studies have linked NRF1 inactivation to the development of nonalcoholic steatohepatitis [33], while YY1 upregulation has been associated with fatty liver diseases [17], whereas E2F4 was found to promote HCC proliferation [37,38]. The gene discussed is YY1; the disease is metabolic dysfunction-associated steatohepatitis.